Stephanie Moquin

5PUBLICATIONS
56CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsProteins and peptidesMolecular targetsNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 22, 2026
The Scope Concept: Defined Chemical Space for Identifying Ligand-Efficient, Tractable Hits Applied to Drug Discovery Targets Trypanosomal CLK1, 14-3-3/Estrogen Receptor-α, and SARS-CoV-2 Mpro.

|Feb 09, 2026
Discovery of EGT710, an Oral Nonpeptidomimetic Reversible Covalent SARS-CoV-2 Main Protease Inhibitor.

Julien P N Papillon, Jun Yuan, Matthew J Hesse

|Jan 16, 2026
Cooperativity and communication between the active sites of the dimeric SARS-CoV-2 main protease.

Sarah N Zvornicanin, Ala M Shaqra, Julia Flynn

|Nov 27, 2025
Structural Analysis of Inhibitor Binding to the Feline Enteric Coronavirus (FECV) Main Protease.

Arooma Maryam, Stephanie A Moquin, Dustin Dovala

|Feb 04, 2021
NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models.

Stephanie A Moquin, Oliver Simon, Ratna Karuna

Pageof 1

Frequent Collaborators

2 joint publications

Dustin Dovala

2 joint publications

Celia A Schiffer

2 joint publications

Ala M Shaqra

2 joint publications

Nese Kurt Yilmaz